RxSight, Inc. announced the transition of Shelley Thunen, the Chief Financial Officer.
Shelley Thunen will stay with the company until her successor is appointed or January 31, 2026.
She will continue to support the company as a consultant post-transition.
Shelley Thunen Transitioning
Shelley Thunen, the CFO of RxSight, is transitioning from her role, leaving behind a significant legacy.
Pivotal Leadership
Thunen's leadership helped guide RxSight through important milestones, including a successful IPO in 2021.
Impact on Company
Thunen's contributions played a crucial role in RxSight's growth and success, shaping the company's foundation.
- Shelley Thunen's departure marks a significant change in RxSight's leadership team.
- Her strategic financial decisions have been instrumental in the company's development and success.
RxSight expresses deep gratitude for Shelley Thunen's contributions and acknowledges her lasting impact on the organization. The company looks forward to continued success in the future.